Previous Close | 1.3450 |
Open | 1.3300 |
Bid | 1.2500 x 100 |
Ask | 1.3600 x 100 |
Day's Range | 1.2850 - 1.3300 |
52 Week Range | 1.1500 - 2.2100 |
Volume | |
Avg. Volume | 238,648 |
Market Cap | 189.834M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3700 |
Earnings Date | Nov 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.10 |
Biodesix ( NASDAQ:BDSX ) Third Quarter 2024 Results Key Financial Results Revenue: US$18.2m (up 35% from 3Q 2023). Net...
Biodesix Inc (BDSX) reports a 35% revenue increase, driven by lung diagnostic testing, despite facing weather-related disruptions and rising expenses.